Immunovant Inc (IMVT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.89B
Last updated: Nov 17, 2026 at 4:10 PM ET
Immunovant Inc (IMVT) Stock Chart
Immunovant (IMVT) has a latest price of $33.21 on Nov 17, 2026, 26.9% below its 52-week high of $45.42. Its price rose 39.9% over the past 12 months. The month-end price rose 262.8% over the 5 years through Oct 2026, a compound annual rate of 29.4%.
Price Chart
From Dec 2019 to Oct 2026, its highest month-end close was $49.19 in Nov 2020 and its lowest $3.90 in Jun 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMVT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMVT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 26.1%, and over 6 months it rose 26.3%. The month-end price fell 11.7% over the 3 years through Oct 2026, a compound annual decline of 4.1%.
| Period | Change |
|---|---|
| 1 month | +20.2% |
| 3 months | -26.1% |
| 6 months | +26.3% |
| 12 months | +39.9% |
| 12 months, with dividends | +39.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -11.7% | -4.1% |
| 5 years | +262.8% | +29.4% |
Price by Year
Its best calendar year was 2020, when the price rose 191.1%, and its weakest was 2021, when it fell 81.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $29.17 | +14.8% |
| 2025 | $25.42 | +2.6% |
| 2024 | $24.77 | -41.2% |
| 2023 | $42.13 | +137.4% |
| 2022 | $17.75 | +108.3% |
| 2021 | $8.52 | -81.6% |
| 2020 | $46.19 | +191.1% |
Trading Range
The price is 2.5% above its 50-day average of $32.39 and 2.4% above its 200-day average of $32.42.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $33.21 | |
| 52-week high | $45.42 | -26.9% |
| 52-week low | $21.86 | +51.9% |
| 50-day average | $32.39 | +2.5% |
| 200-day average | $32.42 | +2.4% |
Price Risk
Over 3 years, its largest fall from a peak was 69.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.54 |
| Largest fall, 1 year | -40.5% |
| Largest fall, 3 years | -69.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMVT
What is IMVT's 1-year price change?
Immunovant's price rose 39.9% over the past 12 months. With dividends included, the 12-month total return was 39.9%.
What is IMVT's 5-year price change?
Immunovant's month-end price rose 262.8% over the 5 years through Oct 2026, a compound annual rate of 29.4%. These figures leave out dividends.
What is IMVT's 52-week high and low?
Immunovant's 52-week high is $45.42 and its 52-week low is $21.86. Its latest price of $33.21 on Nov 17, 2026 is 26.9% below the high.
What is IMVT's beta?
Immunovant's 1-year beta against the S&P 500 is 1.54, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 40.5%.
Is the IMVT chart free?
Yes. Advanced Charting for IMVT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMVT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors